Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XOZZH
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-HER2 antibody-drug conjugate (Mersana Therapeutics/Genentech)
|
|||||
| Synonyms |
Anti-HER2 antibody-drug conjugate (Mersana Therapeutics/Genentech)
Click to Show/Hide
|
|||||
| Organization |
Mersana Therapeutics, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Special Approval(s) |
Orphan drug(FDA)
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.